PBTH - daily chart: PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. PROLOR Biotech Inc PBTH | 8/24/2010 7:30:00 AM NES-ZIONA, Israel, Aug 24, 2010 /PRNewswire via COMTEX News Network/ -- http://www.stockhouse.com/News/USReleasesDetail.aspx?n=7850136 http://stockcharts.com/c-sc/sc?s=pbth&p=D&yr=0&mn=4&dy=0&i=p23001212636&r=4353